Further validation studies may have to be performed using a larger sample cohort to provide a statistically comparison between HNSCC and healthy control groups and thereby to confirm the role of IL-8 and NOD1 as biomarkers of HNSCC. This evidence concerns the gene CXCL8 and head and neck squamous cell carcinoma.